期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Study on the mechanism of apoptosis of myelocytic leukemia cell lines induced by curcumin 被引量:3
1
作者 Fanjun Cheng Qiang Yu Qinbing Zeng Qihuan Liu Keying Xue 《The Chinese-German Journal of Clinical Oncology》 CAS 2008年第2期111-114,共4页
Objective: To investigate the mechanism of apoptosis of myelocytic leukemia lines NB4, K562 and THP-1 cells induced by curcumin. Methods: After the cells were treated with curcumin at different concentration (25, 12.5... Objective: To investigate the mechanism of apoptosis of myelocytic leukemia lines NB4, K562 and THP-1 cells induced by curcumin. Methods: After the cells were treated with curcumin at different concentration (25, 12.5, 6.25, 3.125, 0 μmol/L) for various times (0, 12, 24, 48 h), flow cytometry (FCM) was used to determine the rate of apoptosis of cells. After the cells were treated with curcumin at 25 μmol/L for 24 h, flow cytometry was used to determine the expression level of Fas, and Western blot was performed to determine the expression of Caspase-8 and Caspase-9. Results: (1) Curcumin could induced the apoptosis of NB4, K562 and THP-1 cells in a time- and dose-dependent manner. After the cells were treated with curcumin at 25 μmol/L for 48 h, the rate of apoptosis of cells was over fifty percent. (2) Fas level showed remarkable increase (P < 0.01) after above cells were treated with 25 μmol/L curcumin for 24 h. (3) The apoptosis proteins of Caspase-8 and Cas- pase-9 were also increased obviously (P < 0.01) after the cells were treated with 25 μmol/L curcumin for 24 h. Conclusion: The molecular pathway of apoptosis of myelocytic leukemia lines induced by curcumin are concerned with death receptor and mitochondria. 展开更多
关键词 CURCUMIN APOPTOSIS myelocytic leukemia cell lines
下载PDF
First platelet transfusion refractoriness in a patient with acute myelocytic leukemia: A case report 被引量:1
2
作者 Sheng-Ke Tu Hong-Jie Fan +3 位作者 Zi-Wei Shi Xiao-Lan Li Min Li Kui Song 《World Journal of Clinical Cases》 SCIE 2023年第29期7156-7161,共6页
BACKGROUND Platelet transfusion is of great significance in the treatment of thrombocytopenia caused by myelosuppression during intensive chemotherapy in patients with acute leukemia.In recent years,with platelet tran... BACKGROUND Platelet transfusion is of great significance in the treatment of thrombocytopenia caused by myelosuppression during intensive chemotherapy in patients with acute leukemia.In recent years,with platelet transfusion increasing,ineffective platelet transfusion has become increasingly prominent.Generally speaking,platelet antibodies can be produced after repeated transfusion,thus rendering subsequent platelet transfusion ineffective.We report a case of first platelet transfusion refractoriness(PTR)in a patient with acute myelocytic leukemia(AML).Due to the rarity of such cases in clinical practice,there have been no relevant case reports so far.CASE SUMMARY A 51-year-old female patient attended the hospital due to throat pain and abnormal blood cells for 4 d.Her diagnosis was acute myelocytic leukemia[M2 type Fms related receptor tyrosine kinase 3,Isocitrate Dehydrogenase 1,Nucleophosmin 1,Neuroblastoma RAS viral oncogene homolog(+)high-risk group].She was treated with"IA"(IDA 10 mg day 1-3 and Ara-C 0.2 g day 1-5)chemotherapy.When her condition improved,the patient was discharged from the hospital,instructed to take medicine as prescribed by the doctor after discharge,and returned to the hospital for further chemotherapy on time.CONCLUSION We report a rare case of first platelet transfusion failure in a patient with AML during induction chemotherapy,which may be related to the production of platelet antibodies induced by antibiotics and excessive tumor load.This also suggests that we should consider the influence of antibiotics when the rare situation of first platelet transfusion failure occurs in patients with AML.When platelet antibodies are produced,immunoglobulins can be used to block antibodies,thereby reducing platelet destruction.For patients with PTR,both immune and non-immune factors need to be considered and combined in clinical practice along with individualized treatment to effectively solve the problem. 展开更多
关键词 Acute myelocytic leukemia First platelet transfusion refractoriness MYELOSUPPRESSION Nonimmune causes Immune-mediated causes Case report
下载PDF
Mobilization for peripheral blood stem cells of acute myelocytic leukemia by IL-11 combined with G-CSF
3
《中国输血杂志》 CAS CSCD 2001年第S1期416-,共1页
关键词 Mobilization for peripheral blood stem cells of acute myelocytic leukemia by IL-11 combined with G-CSF STEM IL
下载PDF
Analysis of mechanism on Indigo Naturalis in treating chronic myelocytic leukemia based on two-dimentional model of protein-protein interaction network-moleculardocking technique
4
作者 Cun Liu Xiao-Ming Zhang +3 位作者 Li-Juan Liu Chao Zhou Hong Liu Jing Zhuang 《TMR Theory and Hypothesis》 2018年第1期13-17,共5页
To explore the molecular mechanism of Ind-igo Naturalis in intervening chronic myelocytic leukemia (CML) under the guidance of protein-protein interaction network, the molecular docking technique and in vitro c... To explore the molecular mechanism of Ind-igo Naturalis in intervening chronic myelocytic leukemia (CML) under the guidance of protein-protein interaction network, the molecular docking technique and in vitro cell experiment were chosen. CML-related genes were obtained from the online mendelian inheritance in man database (OMIM), then String 10. 0 was used for text mining and constructing the CML protein-protein interaction network. The interaction data were input in Cytoscape 3. 4. 0 software. Plug-in CentiScaPe 2. 1 was used for implement topology analysis. Small active substances of Indigo Naturalis were obtained from a third-party database, which were optimized by Chemoffice 8. 0 and Sybyl 8. 1, then small molecular ligand library was obtained. The molecular docking was carried out by Surflex-Dock module, the key target was received after scoring. Protein-protein interaction network of CML was constructed, which was consisted of 425 nodes ( proteins) and 2 799 sides ( interactions). The key gene J.AK2 was got. CML is a polygenic disease and JAK2 is likely to be a key node. 展开更多
关键词 Indigo Naturalis Chronic myelocytic leukemia PROTEIN Interaction network Molecular docking
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部